Patients with previously treated advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) lived significantly longer and saw improved disease control when treated with the next-generation KRAS-targeted therapy divarasib, according to researchers from The University of Texas MD Anderson Cancer Center.
From Promise to Proof: Personalized Melanoma mRNA Vaccine Delivers Phase III Success American Association for Cancer Research (AACR)
This Breakthrough Cancer Treatment Can Cut Risk by 42 Percent Inc.com
A rare, aggressive cancer, commonly found in the uterus, limbs and abdomen, behaves differently depending on where it is found in the body, according to new research.
Third of Brain Tumor Patients Benefit From Precision Approach in IMPRESS-Norway Study GenomeWeb
Martha Raymond: Big Questions in Oncology at ESMO 2026 Oncodaily
Ivonescimab Plus Chemotherapy Improves OS and PFS in Advanced Biliary Tract Cancer - Akeso Biopharma Oncodaily
ЧЕЧНЯ. Онкоскрининг в Чечне спасает жизни: за 2,5 месяца выявлено 6 случаев рака на ранней стадии ИА Чеченинфо
Цифровые модели опухолей предсказали ответ на лечение в 74% случаев — News-Medical UA.NEWS
Тарлатамаб с дурвалумабом продлил жизнь при мелкоклеточном раке легкого the Pharma Media
Q&A: Could a new melanoma vaccine change cancer treatment? UVA Today
New drug effectively decreases recurrence of and death from endometrial cancer News-Medical
'Magic Drug' Reduces Risk of Death by 44% in Lung Cancer Trial MedPage Today
